ClinConnect ClinConnect Logo
Search / Trial NCT01411852

Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma

Launched by UNIVERSITY OF WASHINGTON · Aug 4, 2011

Trial Information

Current as of May 25, 2025

Completed

Keywords

Fluid Volume Resuscitation Trauma Hemorrhagic Shock

ClinConnect Summary

1. Overview This multi-center pilot trial is designed to determine the feasibility and safety of hypotensive resuscitation for the early resuscitation of patients with traumatic shock compared to standard fluid resuscitation. Blunt and penetrating trauma patients with a prehospital systolic blood pressure (SBP) ≤ 90 mmHg will be eligible. In the hypotensive resuscitation group, an intravenous line (IV) will be placed and a radial pulse will be palpated. If the radial pulse is present or the SBP is greater than or equal to 70, a 250 ml bag of normal saline will be hung and maintained at a ke...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Included will be those with:
  • Blunt or penetrating injury
  • Age ≥15yrs or weight ≥50kg if age is unknown
  • Prehospital SBP ≤ 90 mmHg
  • Exclusion Criteria: Excluded will be those with:
  • Ground level falls
  • Evidence of severe blunt or penetrating head injury with a Glasgow Coma Scale (GCS) ≤ 8
  • Bilateral paralysis secondary to suspected spinal cord injury
  • Fluid greater than 250ml was given prior to randomization
  • Cardiopulmonary resuscitation (CPR) by Emergency Medicine Service (EMS) prior to randomization
  • Known prisoners
  • Known or suspected pregnancy
  • Drowning or asphyxia due to hanging
  • Burns over a Total Body Surface Area (TBSA) \> 20%
  • Time of call received at dispatch to study intervention \> 4 hours

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Portland, Oregon, United States

Dallas, Texas, United States

Milwaukee, Wisconsin, United States

Pittsburgh, Pennsylvania, United States

Birmingham, Alabama, United States

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Myron L Weisfeldt, MD

Study Chair

Resuscitation Outcomes Consortium

David Hoyt, MD

Study Director

Resuscitation Outcomes Consortium

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials